Loading...
Guest User
Welcome! Please login.
* - Tentative Dates
The Company intends to utilize the Net Proceeds from the Issue towards funding the following objects:
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 1,951.72 | 2,060.1 | 1,800.08 |
| Revenue | 1,628.62 | 1,687.36 | 1,445.12 |
| Profit After Tax | -104.88 | 39.81 | 60.37 |
| Amount in ₹ Crore | |||
Camlin Fine Sciences (CFS) manufactures and sells chemicals, ingredients, and additive blends. It manufactures chemicals such as hydroquinone and catechol, antioxidants such as butyl hydroquinone (TBHQ) and Butylated hydroxyanisole (BHA), and aroma ingredients.
It has manufacturing facilities in India and Italy and R&D centers in Europe, North America, and South America. The company has a strong supply chain in the North, Central, and South America, Europe, and Asia-Pacific.